Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ)
CNY 21.47
(3.02%)
CNY 21.47
(3.02%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | 15.12% |
| 2022 | 900.7 Million CNY | 12.9% |
| 2021 | 797.77 Million CNY | 9.46% |
| 2020 | 728.82 Million CNY | 9.88% |
| 2019 | 663.3 Million CNY | 26.39% |
| 2018 | 524.8 Million CNY | 32.99% |
| 2017 | 394.63 Million CNY | 27.41% |
| 2016 | 309.74 Million CNY | 19.89% |
| 2015 | 258.34 Million CNY | 15.71% |
| 2014 | 223.27 Million CNY | 26.68% |
| 2013 | 176.25 Million CNY | 26.17% |
| 2012 | 139.69 Million CNY | 32.23% |
| 2011 | 105.64 Million CNY | 38.22% |
| 2010 | 76.43 Million CNY | 39.8% |
| 2009 | 54.67 Million CNY | 34.33% |
| 2008 | 40.69 Million CNY | 52.69% |
| 2007 | 26.65 Million CNY | 56.95% |
| 2006 | 16.98 Million CNY | 0.95% |
| 2005 | 16.82 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 363.63 Million CNY | 37.08% |
| 2024 Q3 | 391.18 Million CNY | 7.58% |
| 2024 Q1 | 265.28 Million CNY | 75.36% |
| 2023 Q1 | 227.42 Million CNY | 42.99% |
| 2023 FY | 1.03 Billion CNY | 15.12% |
| 2023 Q4 | 151.27 Million CNY | -55.63% |
| 2023 Q3 | 340.93 Million CNY | 7.46% |
| 2023 Q2 | 317.27 Million CNY | 39.5% |
| 2022 FY | 900.7 Million CNY | 12.9% |
| 2022 Q3 | 294.37 Million CNY | 13.74% |
| 2022 Q2 | 258.81 Million CNY | 37.17% |
| 2022 Q1 | 188.68 Million CNY | 51.11% |
| 2022 Q4 | 159.05 Million CNY | -45.97% |
| 2021 Q3 | 262 Million CNY | 7.77% |
| 2021 FY | 797.77 Million CNY | 9.46% |
| 2021 Q1 | 167.79 Million CNY | 6.6% |
| 2021 Q2 | 243.11 Million CNY | 44.89% |
| 2021 Q4 | 124.86 Million CNY | -52.34% |
| 2020 Q4 | 157.39 Million CNY | -28.0% |
| 2020 FY | 728.82 Million CNY | 9.88% |
| 2020 Q1 | 137.9 Million CNY | -3.27% |
| 2020 Q3 | 218.6 Million CNY | 1.72% |
| 2020 Q2 | 214.91 Million CNY | 55.85% |
| 2019 Q2 | 195.98 Million CNY | 55.78% |
| 2019 Q3 | 198.96 Million CNY | 1.52% |
| 2019 FY | 663.3 Million CNY | 26.39% |
| 2019 Q1 | 125.8 Million CNY | 22.61% |
| 2019 Q4 | 142.56 Million CNY | -28.35% |
| 2018 Q2 | 160.13 Million CNY | 57.38% |
| 2018 FY | 524.8 Million CNY | 32.99% |
| 2018 Q4 | 102.6 Million CNY | -35.99% |
| 2018 Q1 | 101.75 Million CNY | 103.33% |
| 2018 Q3 | 160.3 Million CNY | 0.11% |
| 2017 Q3 | 135.41 Million CNY | 9.34% |
| 2017 Q1 | 85.31 Million CNY | 53.51% |
| 2017 FY | 394.63 Million CNY | 27.41% |
| 2017 Q4 | 50.04 Million CNY | -63.05% |
| 2017 Q2 | 123.85 Million CNY | 45.18% |
| 2016 Q3 | 82.23 Million CNY | -19.12% |
| 2016 FY | 309.74 Million CNY | 19.89% |
| 2016 Q1 | 70.26 Million CNY | 65.48% |
| 2016 Q4 | 55.57 Million CNY | -32.42% |
| 2016 Q2 | 101.66 Million CNY | 44.69% |
| 2015 Q3 | 69.53 Million CNY | -19.44% |
| 2015 Q2 | 86.3 Million CNY | 43.75% |
| 2015 FY | 258.34 Million CNY | 15.71% |
| 2015 Q1 | 60.04 Million CNY | 46.72% |
| 2015 Q4 | 42.46 Million CNY | -38.93% |
| 2014 Q4 | 40.92 Million CNY | -30.24% |
| 2014 FY | 223.27 Million CNY | 26.68% |
| 2014 Q3 | 58.66 Million CNY | -22.63% |
| 2014 Q2 | 75.82 Million CNY | 58.44% |
| 2014 Q1 | 47.85 Million CNY | 56.83% |
| 2013 Q2 | 60.58 Million CNY | 58.76% |
| 2013 Q3 | 46.99 Million CNY | -22.44% |
| 2013 Q4 | 30.51 Million CNY | -35.06% |
| 2013 FY | 176.25 Million CNY | 26.17% |
| 2013 Q1 | 38.16 Million CNY | 62.49% |
| 2012 Q3 | 39.39 Million CNY | -16.51% |
| 2012 FY | 139.69 Million CNY | 32.23% |
| 2012 Q4 | 23.48 Million CNY | -40.38% |
| 2012 Q1 | 29.64 Million CNY | 60.79% |
| 2012 Q2 | 47.18 Million CNY | 59.18% |
| 2011 Q1 | 21.9 Million CNY | 88.44% |
| 2011 FY | 105.64 Million CNY | 38.22% |
| 2011 Q3 | 29.81 Million CNY | -16.0% |
| 2011 Q4 | 18.43 Million CNY | -38.17% |
| 2011 Q2 | 35.49 Million CNY | 62.01% |
| 2010 Q4 | 11.62 Million CNY | -47.26% |
| 2010 FY | 76.43 Million CNY | 39.8% |
| 2010 Q3 | 22.04 Million CNY | -15.09% |
| 2010 Q2 | 25.96 Million CNY | 54.48% |
| 2010 Q1 | 16.8 Million CNY | 65.36% |
| 2009 Q4 | 10.16 Million CNY | -31.57% |
| 2009 FY | 54.67 Million CNY | 34.33% |
| 2009 Q1 | 11.3 Million CNY | 23.79% |
| 2009 Q3 | 14.85 Million CNY | -19.05% |
| 2009 Q2 | 18.34 Million CNY | 62.23% |
| 2008 Q4 | 9.13 Million CNY | -15.55% |
| 2008 Q3 | 10.81 Million CNY | -13.68% |
| 2008 Q2 | 12.53 Million CNY | 52.63% |
| 2008 Q1 | 8.21 Million CNY | 21.96% |
| 2008 FY | 40.69 Million CNY | 52.69% |
| 2007 Q3 | 10.27 Million CNY | 0.0% |
| 2007 Q4 | 6.73 Million CNY | -34.49% |
| 2007 FY | 26.65 Million CNY | 56.95% |
| 2006 FY | 16.98 Million CNY | 0.95% |
| 2005 FY | 16.82 Million CNY | 0.0% |